Table 3.
CS Derivative |
Other Compounds |
Cell Type | Bioink Formulation | Bioprinting Method | Condition | Application | Ref. |
---|---|---|---|---|---|---|---|
MeGC | - | Human osteosarcoma cell line (1 × 106 cells/mL) |
MeGC: 3% w/v, riboflavin: 12 μΜ Crosslinker: UV for 70 s |
Extrusion based | Nozzle: 26 G Pressure: 120 ± 10 kPa Temperature: 25 °C Speed: 6 mm/s |
Bone tissue engineering |
[23] |
CS-MA | β-glycerophosphate, lithium phenyl-2,4,6-trimethylbenzoylphospinate |
Fibroblasts (NIH/3T3) (106 cells/mL), osteoblast-like cells (Saos-2) and neuronal-like cells (SH-SY5Y) |
CS-MA: 1.5 % w/v, βGP:0.5 g/mL, LAP: 0.05% w/v Crosslinker: UV |
Extrusion based | Nozzle: 25 G Temperature: Printhead: 4 °C Printing bed: 37 °C Speed: 10 mm/s |
- | [24] |
CS-MA | Phosphorylated-oligo [poly(ethylene glycol)fumarate], Acrylated montmorillonite, Methyl cellulose, Gelatin |
Pre-osteoblast cells (MC3T3-E1) (1.5 × 106 cells/mL) |
MEGC: 2% w/v MMT: 0%, 1%, 4%, 6% Irgacure 2959 1.5 wt.% of total polymer content Crosslinker: UV |
Extrusion based | Nozzle: 25 G Pressure: 50 kPa Temperature: 25 °C printing bed: 4 °C Speed:10 mm/s |
Bone tissue engineering |
[25] |
GC | Oxidized hyaluronate, Adipic acid dihydrazide, Alginate |
ATDC5 cells (1 × 107 cells/mL) |
GC: 1 wt.% OHA: 2 wt.% ADH: 0.3% ALG 0.3 wt.% Crosslinker: CaCl2 60 mM |
Extrusion based | Nozzle: 25 G Pressure: 300 N Temperature: 25 °C |
- | [27] |
NOCC | Agarose | Neuro2a mouse Neuroblastoma Cells (1 × 105 cells/mL) |
Agarose: 40% NOCC: 60% |
Extrusion based | Nozzle: 0.41 mm Temperature: 37 °C Speed: 3 mm/s |
- | [28] |
NOCC | Gelatin, Na-Polyphosphate NPs, Alginate |
Mesenchymal stem cells (MSC) (3 × 105 cells/mL) |
NOCC: 50 mg/mL Gelatin: 25 mg/mL Na-polyP: 100 μg/mL Alginate: 1% Crosslinker: CaCl2 2.5% w/v |
Extrusion based | Temperature: 21 °C Pressure: 1 bar Temperature: room temperature Speed: 18 mm/s |
- | [29] |
CMC | Aldehyde hyaluronic acid, Gelatin, 4-arm poly(ethylene glycol) succinimidyl glutarate |
NIH/3T3 fibroblasts CRL1658 and C2C12 myoblasts |
AHA: 1% w/v CMC: 0.75% w/v GEL: 1% w/v PEG-SG: 0.5% w/v |
Extrusion based | Nozzle: 25 G Temperature: 10 °C Speed: linear: 6 mm/s extrusion: 0.07 mL/min |
- | [30] |
CMC | Methacryloyl gelatin | Bone marrow mesenchymal stem cells (BMSCs) (3 × 105 cells/mL) |
CMC: 4% w/v LAP: 0.3% w/v 10% GelMA/0.5% CMCS 10% GelMA/1% CMCS 10% GelMA/2% CMCS |
Extrusion based | Nozzle: 160 μm Pressure: non cellular inks: 0.8–1.2 bar cell-laden: 0.5–1 bar Speed: Cell-laden: 10–20 mm/s Cell-free: 15 mm/s Temperature: 16 °C |
Vascular tissue engineering |
[31] |
CMC | Oxidized and non-oxidized hyaluronic acid | Fibroblasts (L929) (1 × 106 cell/mL) |
CMC: 2 wt.% HA: 0.4 wt.% Oxidized HA: 4 wt.% Catechol NPs: 2 and 29 M % Crosslinker: FeCl3 20 mM |
Extrusion based | Nozzle: 200 μm Speed: plunger: 0.06 mm/s, printhead: 15 mm/s | - | [32] |
CS-Ph | Dibenzaldehyde- terminated telechelic poly(ethylene glycol) |
Human mesenchymal stem cells (hMSCs) (4 × 106 cells/mL) |
Chi-Ph: 1% Crosslinker:DF-PEG 1%, UV (440–460 nm) |
Extrusion based | Nozzle: 26 G | Bone tissue engineering |
[34] |
HBC | Thiolated hyaluronic acid, Vinyl sulfonated hyaluronic acid, Matrigel |
Neural stem cells (NSCs) |
HBC: 3% w/v, HA-SH: 0.3% w/v, HA-VS: 0.3% w/v, MA: 0.1% w/v |
Extrusion based | Nozzle: 260 μm Temperature: printhead: 37 °C printbed: 10 °C, Pressure: 20 kPa |
Neural tissue engineering |
[36] |
HPC microspheres |
Methacryloyl gelatin, poly(γ-glutamic acid) |
Adiposed derived stem cells (ASCs) |
GelMA: 5 wt.%, HPC-microspheres:50 mg/mL, PG-microspheres: 50 mg/mL, I2959 Crosslinker: UV |
Extrusion based | Nozzle: 18 G Temperature: 25 °C Speed: 5 mm/s |
- | [37] |
HBC | Oxidized chondroitin sulfate | Bone-marrow mesenchymal stem cells (BMSCs) (5 × 106 cells/mL) |
GelMA: 13% w/v, Irgacure 2959: 0.2% w/v, Peptide/CD gel concentration: 0.02%/8% SC/0.6% DA, Crosslinker: UV | Extrusion based | Nozzle: core: 400 μm, shell: 800 μm, temperature: printhead: 25 °C, printbed:16 °C, Pressure: core: 225 kPa, shell: 150 kPa, Speed: 5 mm/s |
Wound healing | [38] |